| Literature DB >> 28679986 |
Haruna Shibayama1,2, Ken-Ichi Imadome3, Erika Onozawa1,2, Akiho Tsuzura1, Osamu Miura1, Takatoshi Koyama2, Ayako Arai1,2.
Abstract
Chronic active Epstein-Barr virus infection (CAEBV) is a disease characterized by clonally proliferating and activated EBV-infected T or NK cells accompanied by chronic inflammation and T- or NK-cell neoplasms. However, the mechanism for developing CAEBV has not been clarified to date. Because the decreased number or inactivation of EBV-specific cytotoxic T lymphocytes (CTLs) resulted in the development of EBV-positive B-cell neoplasms, we investigated the number of CTLs in CAEBV patients using the tetrameric complexes of HLA-restricted EBV-specific peptides. Among the seven patients examined, EBV-specific CTLs were detected in the peripheral blood mononuclear cells (PBMCs) of four cases but were not detected in three cases. The ratio of EBV-specific CTLs in PBMCs tended to be higher in the patients with active disease than in those with inactive disease. In two patients in whom EBV-specific CTLs had not been detected, CTLs appeared after the eradication of EBV-infected T cells by allogeneic bone marrow transplantation. These results suggested that the failure of CTLs had a role in developing CAEBV, although the induction number and function of EBV-specific CTLs might vary in each patient.Entities:
Keywords: Chronic active Epstein-Barr virus infection; Cytotoxic T lymphocyte
Mesh:
Substances:
Year: 2017 PMID: 28679986 DOI: 10.11406/rinketsu.58.583
Source DB: PubMed Journal: Rinsho Ketsueki ISSN: 0485-1439